Abstract

<h3>Abstract</h3> Serum antibodies IgM and IgG are elevated during COVID-19 to defend against viral attack. Atypical results such as negative and abnormally high antibody expression were frequently observed whereas the...

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title
Journal
Date
Author
Proteomics Investigation of Diverse Serological Patterns in COVID-19
Xiao Liang ...
Molecular & cellular proteomics : MCP | VOL. 22
Xiao Liang, et. al.Xiao Liang ...
05 Jan 2023
Investigation of IL-6 serum level in COVID-19 patients with positive COVID-19 IgG/IgM antibody titers to check inflammation and disease progression
Samaneh Mollazadeh ... Seyed-Alireza Esmaeili
Cytokine | VOL. 177
Samaneh Mollazadeh, et. al.Samaneh Mollazadeh ... Seyed-Alireza Esmaeili
02 Mar 2024
High and Persistent Anti-GM1 Antibody Titers Are Associated With Poor Clinical Recovery in Guillain-Barré Syndrome.
Robin C.M Thomma ... Pieter A Van Doorn
Neurology Neuroimmunology &amp; Neuroinflammation | VOL. 10
Robin C.M Thomma, et. al.Robin C.M Thomma ... Pieter A Van Doorn
14 Apr 2023
The Characteristics of ABO Antibodies in Group O Thai Blood Donors
Kamontip Khampanon ... Thanaporn Chanprakop
Journal of clinical laboratory analysis | VOL. 26
Kamontip Khampanon, et. al.Kamontip Khampanon ... Thanaporn Chanprakop
01 Jul 2012
View more papers

More From: Journal for ImmunoTherapy of Cancer

Paper Title
Journal
Date
Author
A crisis in clinical research
David S Hong ... Mario Sznol
Journal for ImmunoTherapy of Cancer | VOL. 12
David S Hong, et. al.David S Hong ... Mario Sznol
11 Jul 2024
Plasma metabolomics of immune-related adverse events for patients with lung cancer treated with PD-1/PD-L1 inhibitors
Juan Chen ... Zhaoqian Liu
Journal for ImmunoTherapy of Cancer | VOL. 12
Juan Chen, et. al.Juan Chen ... Zhaoqian Liu
11 Jul 2024
Correction: ASCC3 promotes the immunosuppression and progression of non-small cell lung cancer by impairing the type I interferon response via CAND1-mediated ubiquitination inhibition of STAT3
-
Journal for ImmunoTherapy of Cancer | VOL. 12
--
10 Jul 2024
Hypothesis: the generation of T cells directed against neoepitopes employing immune-mediating agents other than neoepitope vaccines
Jeffrey Schlom ... James L Gulley
Journal for ImmunoTherapy of Cancer | VOL. 12
Jeffrey Schlom, et. al.Jeffrey Schlom ... James L Gulley
08 Jul 2024
View more papers